TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 34769571

Group type: EXPERIMENTAL
Intervention: Robot-assisted learning system (RobotLS)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Video-assisted learning system (VideoLS)
Number of subjects: 60
Study: 32333641

Group type: EXPERIMENTAL
Intervention: MSB11455 (6 mg/0.6 mL)
Number of subjects: 336

Group type: COMPARATOR
Intervention: Neulasta® (6 mg/0.6 mL)
Number of subjects: 336

Group type: EXPERIMENTAL
Intervention: MSB11455 and Neulasta®
Number of subjects: 336
Study: 33279955

Group type: EXPERIMENTAL
Intervention: Active dual-chamber pacemaker (pacing ON)
Number of subjects: 127

Group type: COMPARATOR
Intervention: Inactive dual-chamber pacemaker (pacing OFF)
Number of subjects: 127
Study: 32164428

Group type: EXPERIMENTAL
Intervention: Nitroglycerin infusion (0.5 mcg/kg/min)
Number of subjects: 53

Group type: EXPERIMENTAL
Intervention: Nitroglycerin infusion
Number of subjects: 53

Group type: COMPARATOR
Intervention: Placebo infusion
Number of subjects: 53
Study: 34229259

Group type: EXPERIMENTAL
Intervention: High intake of processed meat
Number of subjects: 415524

Group type: COMPARATOR
Intervention: 24‐h urinary sodium (UNa)
Number of subjects: 415524

Group type: COMPARATOR
Intervention: Mendelian randomization analysis of UNa
Number of subjects: 415524
Study: 35450681

Group type: EXPERIMENTAL
Intervention: PFHP + TRB
Number of subjects: 443

Group type: COMPARATOR
Intervention: TRB
Number of subjects: 443
Study: 32500486

Group type: EXPERIMENTAL
Intervention: Fluoxetine 20 mg once daily plus Metformin 1000 mg once daily for 12 weeks
Number of subjects: 80

Group type: COMPARATOR
Intervention: Fluoxetine 20 mg once daily plus placebo for 12 weeks
Number of subjects: 80
Study: 34097231

Group type: EXPERIMENTAL
Intervention: 10 days of antibiotic therapy
Number of subjects: 70

Group type: COMPARATOR
Intervention: 14 days of antibiotic therapy
Number of subjects: 70
Study: 33770125

Group type: EXPERIMENTAL
Intervention: Body mass index (BMI) <18.5 kg/m2
Number of subjects: 200

Group type: EXPERIMENTAL
Intervention: Early coitarche
Number of subjects: 200

Group type: EXPERIMENTAL
Intervention: History of using oral contraceptive pills
Number of subjects: 200

Group type: EXPERIMENTAL
Intervention: Lifetime sexual transmitted infections
Number of subjects: 200

Group type: EXPERIMENTAL
Intervention: Multiple sexual partners
Number of subjects: 200

Group type: COMPARATOR
Intervention: BMI ≥25 kg/m2
Number of subjects: 200

Group type: COMPARATOR
Intervention: Level of education of college and above
Number of subjects: 200
Study: 32954812

Group type: EXPERIMENTAL
Intervention: FreeStyle Libre 2 System
Number of subjects: 273
Study: 33291070

Group type: EXPERIMENTAL
Intervention: High Contextual Interference (HCI)
Number of subjects: 35

Group type: COMPARATOR
Intervention: Low Contextual Interference (LCI)
Number of subjects: 35
Study: 35726289

Group type: EXPERIMENTAL
Intervention: Endoscopic retrograde cholangiopancreatography (ERCP) combined with endoscopic sphincterotomy (EST)
Number of subjects: 100

Group type: COMPARATOR
Intervention: Control group (open surgery)
Number of subjects: 100
Study: 34253715

Group type: EXPERIMENTAL
Intervention: tolcapone
Number of subjects: 30
Study: 32198342

Group type: EXPERIMENTAL
Intervention: Lidocaine (1.5 mg/kg bolus over 30 min, followed by 1 mg/kg/h continuous infusion for 6 h)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo (control)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Lidocaine
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control
Number of subjects: 0
Study: 33962592

Group type: EXPERIMENTAL
Intervention: CPI treatment combined with SBRT (Arm A)
Number of subjects: 98

Group type: COMPARATOR
Intervention: CPI monotherapy (Arm B)
Number of subjects: 98
Study: 32997046

Group type: EXPERIMENTAL
Intervention: POC‐CCA test
Number of subjects: 217

Group type: COMPARATOR
Intervention: RS (16 Kato‐Katz slides and Helmintex® method)
Number of subjects: 217

Group type: EXPERIMENTAL
Intervention: Post-treatment evaluation
Number of subjects: 217

Group type: EXPERIMENTAL
Intervention: POC‐CCA test post-treatment
Number of subjects: 217
Study: 35766397

Group type: EXPERIMENTAL
Intervention: Virtual coaching program (three 1:1 coaching sessions over 9 months)
Number of subjects: 237

Group type: COMPARATOR
Intervention: Control (e-mailed wellness resources)
Number of subjects: 237
Study: 33341955

Group type: EXPERIMENTAL
Intervention: Tegoprazan (50 mg and 100 mg) coadministered with amoxicillin/clarithromycin (1000/500 mg) for 7 days
Number of subjects: 0

Group type: COMPARATOR
Intervention: Pantoprazole-based triple therapy
Number of subjects: 0
Study: 32816839

Group type: EXPERIMENTAL
Intervention: Customised Interactive Computer Education System (CICS)
Number of subjects: 100

Group type: COMPARATOR
Intervention: Pictorial Information Booklet
Number of subjects: 100
Study: 36044101

Group type: EXPERIMENTAL
Intervention: No-ACT group
Number of subjects: 200

Group type: EXPERIMENTAL
Intervention: ACT group
Number of subjects: 200

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 200
Study: 33413594

Group type: EXPERIMENTAL
Intervention: Aspirin 100 mg once daily for 36 months
Number of subjects: 554

Group type: COMPARATOR
Intervention: Matching inactive placebo for 36 months
Number of subjects: 554
Study: 36314226

Group type: EXPERIMENTAL
Intervention: CO-OP plus NDT
Number of subjects: 32

Group type: COMPARATOR
Intervention: NDT
Number of subjects: 32
Study: 32860443

Group type: EXPERIMENTAL
Intervention: Mindfulness-based intervention (MI)
Number of subjects: 247

Group type: COMPARATOR
Intervention: Stress management (SM)
Number of subjects: 247
Study: 32955410

Group type: EXPERIMENTAL
Intervention: Induction chemotherapy (IC)
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Concurrent chemotherapy (CC)
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Concurrent chemotherapy plus adjuvant chemotherapy (CC + AC)
Number of subjects: 10

Group type: COMPARATOR
Intervention: Overall comparison of IC, CC, and CC + AC
Number of subjects: 10
Study: 35468847

Group type: EXPERIMENTAL
Intervention: Salbutamol (single intravenous injection)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Standard analgesia
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 32731757

Group type: EXPERIMENTAL
Intervention: Extracorporeal shock wave therapy
Number of subjects: 72

Group type: EXPERIMENTAL
Intervention: Standard care (ultrasound + hot pack + self‐stretch‐exercises)
Number of subjects: 72

Group type: COMPARATOR
Intervention: Control (self‐stretch‐exercises)
Number of subjects: 72
Study: 32521736

Group type: EXPERIMENTAL
Intervention: Escitalopram (SSRI), 6-week treatment
Number of subjects: 16

Group type: COMPARATOR
Intervention: Placebo, 6-week treatment
Number of subjects: 16
Study: 35470201

Group type: EXPERIMENTAL
Intervention: SWEPPE smartphone application for 1 year (n=180)
Number of subjects: 360

Group type: COMPARATOR
Intervention: Control group (n=180)
Number of subjects: 360
Study: 34796851

Group type: COMPARATOR
Intervention: Abatacept
Number of subjects: 213

Group type: COMPARATOR
Intervention: Rituximab
Number of subjects: 213

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 213
Study: 34781008

Group type: EXPERIMENTAL
Intervention: MOCA + 2% POL liquid (2% group)
Number of subjects: 364

Group type: EXPERIMENTAL
Intervention: MOCA + 3% POL liquid (3% group)
Number of subjects: 364

Group type: EXPERIMENTAL
Intervention: Both groups (2% and 3%)
Number of subjects: 364

Group type: EXPERIMENTAL
Intervention: 3% group
Number of subjects: 364

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 364
Study: 33789470

Group type: EXPERIMENTAL
Intervention: Usual education plus an additional module on realistic expectations
Number of subjects: 204

Group type: COMPARATOR
Intervention: Usual preoperative education (control group)
Number of subjects: 204
Study: 33212355

Group type: EXPERIMENTAL
Intervention: Fall Prevention intervention (n=58)
Number of subjects: 118

Group type: COMPARATOR
Intervention: Control group (n=60)
Number of subjects: 118
Study: 33203383

Group type: EXPERIMENTAL
Intervention: Morphological features and ISSR‐based DNA markers analysis
Number of subjects: 38
Study: 34689669

Group type: EXPERIMENTAL
Intervention: Experimental video
Number of subjects: 345

Group type: EXPERIMENTAL
Intervention: NCAA handout
Number of subjects: 345

Group type: COMPARATOR
Intervention: Non-treatment control video
Number of subjects: 345
Study: 33653685

Group type: EXPERIMENTAL
Intervention: High oxygen protocol (6-8 L/min by face mask)
Number of subjects: 40872

Group type: COMPARATOR
Intervention: Low oxygen protocol (Oxygen only if SpO2 < 90%)
Number of subjects: 40872

Group type: EXPERIMENTAL
Intervention: High oxygen protocol (for STEMI patients)
Number of subjects: 40872

Group type: COMPARATOR
Intervention: Low oxygen protocol (for STEMI patients)
Number of subjects: 40872

Group type: EXPERIMENTAL
Intervention: High oxygen protocol (for non-STEMI patients)
Number of subjects: 40872

Group type: COMPARATOR
Intervention: Low oxygen protocol (for non-STEMI patients)
Number of subjects: 40872
Study: 32202620

Group type: EXPERIMENTAL
Intervention: Revised warning statements
Number of subjects: 2505

Group type: COMPARATOR
Intervention: TCA statements
Number of subjects: 2505
Study: 36261056

Group type: EXPERIMENTAL
Intervention: Strength training of the non-hemiplegic side (NHS)
Number of subjects: 139

Group type: COMPARATOR
Intervention: Usual rehabilitation training (control)
Number of subjects: 139
Study: 33542437

Group type: COMPARATOR
Intervention: lopinavir-ritonavir (LPV/r) for 1 year
Number of subjects: 553

Group type: EXPERIMENTAL
Intervention: lamivudine (3TC) for 1 year
Number of subjects: 553
Study: 35025152

Group type: EXPERIMENTAL
Intervention: SUN's abdominal acupuncture
Number of subjects: 80

Group type: COMPARATOR
Intervention: Conventional acupuncture
Number of subjects: 80
Study: 33866729

Group type: COMPARATOR
Intervention: Transconjunctival route repair
Number of subjects: 78

Group type: EXPERIMENTAL
Intervention: Subciliary route repair
Number of subjects: 78
Study: 34734297

Group type: EXPERIMENTAL
Intervention: Coated implant (TiNiN)
Number of subjects: 118

Group type: COMPARATOR
Intervention: Standard implant (CoCr)
Number of subjects: 118
Study: 34488744

Group type: EXPERIMENTAL
Intervention: A-NiTi archwires
Number of subjects: 88

Group type: COMPARATOR
Intervention: Cu-NiTi archwires
Number of subjects: 88
Study: 32235930

Group type: EXPERIMENTAL
Intervention: Underfeeding
Number of subjects: 27

Group type: EXPERIMENTAL
Intervention: Oral vancomycin
Number of subjects: 27

Group type: COMPARATOR
Intervention: Overfeeding
Number of subjects: 27

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 27

Group type: EXPERIMENTAL
Intervention: Underfeeding and Oral vancomycin
Number of subjects: 27

Group type: EXPERIMENTAL
Intervention: Underfeeding and Overfeeding
Number of subjects: 27
Study: 35995733

Group type: EXPERIMENTAL
Intervention: ACB with 20 mL of 0.5% ropivacaine
Number of subjects: 70

Group type: COMPARATOR
Intervention: Control group (no ACB)
Number of subjects: 70
Study: 33785933

Group type: EXPERIMENTAL
Intervention: High-flow nasal cannula (HFNC) therapy
Number of subjects: 20

Group type: COMPARATOR
Intervention: Conventional oxygen therapy
Number of subjects: 20
Study: 32229139

Group type: EXPERIMENTAL
Intervention: 50 g dark chocolate containing 410 mg of flavanols per day
Number of subjects: 100

Group type: COMPARATOR
Intervention: 50 g dark chocolate containing 86 mg of flavanols per day
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 100
Study: 35452108

Group type: EXPERIMENTAL
Intervention: 8-week weight loss and lifestyle intervention (nutritional behavior change, aerobic exercise, sleep hygiene, alcohol and tobacco cessation) combined with usual care (CPAP therapy)
Number of subjects: 89

Group type: COMPARATOR
Intervention: usual care (CPAP therapy)
Number of subjects: 89
Study: 33455786

Group type: EXPERIMENTAL
Intervention: Higher-CP ground starter feed mixed with alkali-processed wheat straw (HP-PWS)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Higher-CP ground starter feed (23.5% CP)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Higher-CP ground starter feed
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Processed wheat straw (PWS) mixed with starter feed
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Processed wheat straw (PWS)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Lower-CP ground starter feed mixed with unprocessed wheat straw (LP-WS)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Lower-CP ground starter feed mixed with alkali-processed wheat straw (LP-PWS)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Higher-CP ground starter feed mixed with unprocessed wheat straw (HP-WS)
Number of subjects: 60
Study: 33263352

Group type: EXPERIMENTAL
Intervention: Music tuned to 432 Hz
Number of subjects: 12

Group type: COMPARATOR
Intervention: Music tuned to 440 Hz
Number of subjects: 12
Study: 35101094

Group type: EXPERIMENTAL
Intervention: BioBlock nasal spray (intervention)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo nasal spray (control)
Number of subjects: 0
Study: 34446480

Group type: EXPERIMENTAL
Intervention: Active tDCS combined with computer‐assisted cognitive training
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: Active tDCS over bilateral temporal cortex (BTC)
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: Active tDCS
Number of subjects: 36

Group type: COMPARATOR
Intervention: Sham tDCS
Number of subjects: 36
Study: 36467457

Group type: COMPARATOR
Intervention: Best medical treatment
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Roux‐en‐Y gastric bypass (RYGB)
Number of subjects: 100
Study: 35273566

Group type: EXPERIMENTAL
Intervention: LT3 monotherapy for 12 weeks
Number of subjects: 59

Group type: COMPARATOR
Intervention: LT4 monotherapy for 12 weeks
Number of subjects: 59

Group type: EXPERIMENTAL
Intervention: LT3 treatment
Number of subjects: 59

Group type: COMPARATOR
Intervention: LT3 vs LT4
Number of subjects: 59
Study: 36182638

Group type: EXPERIMENTAL
Intervention: Grip weakness group (grip strength < 18 kg)
Number of subjects: 90
Study: 33250038

Group type: EXPERIMENTAL
Intervention: Endovascular Therapy (EVT)
Number of subjects: 182

Group type: COMPARATOR
Intervention: Medical management
Number of subjects: 182

Group type: EXPERIMENTAL
Intervention: Endovascular Therapy (EVT) with CT selection
Number of subjects: 182

Group type: EXPERIMENTAL
Intervention: Endovascular Therapy (EVT) with MRI selection
Number of subjects: 182
Study: 32700828

Group type: EXPERIMENTAL
Intervention: Mindfulness training
Number of subjects: 0
Study: 35164833

Group type: EXPERIMENTAL
Intervention: Dietary advice reinforced by weekly supportive phone/email support for 4 weeks.
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Potassium supplement prescribed if no increase in potassium intake after 4 weeks.
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Dietary advice and potassium supplement.
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Concurrent measurements of sodium intake, blood pressure, participant satisfaction, and safety measures.
Number of subjects: 0
Study: 33774529

Group type: EXPERIMENTAL
Intervention: Intralipids
Number of subjects: 64

Group type: EXPERIMENTAL
Intervention: Prednisone
Number of subjects: 64

Group type: COMPARATOR
Intervention: Untreated
Number of subjects: 64

Group type: EXPERIMENTAL
Intervention: Treated embryo transfers
Number of subjects: 64

Group type: EXPERIMENTAL
Intervention: Steroid-treated transfers
Number of subjects: 64

Group type: EXPERIMENTAL
Intervention: Intralipid-treated transfers
Number of subjects: 64
Study: 34676808

Group type: EXPERIMENTAL
Intervention: CPS low group in model 1
Number of subjects: 490

Group type: EXPERIMENTAL
Intervention: CPS 0, 1 and 2 in model 2
Number of subjects: 490
Study: 34020136

Group type: EXPERIMENTAL
Intervention: Couple-Strengths-Oriented Therapeutic Conversations (CO-SOTC) sessions, 3 sessions
Number of subjects: 120
Study: 34715059

Group type: EXPERIMENTAL
Intervention: Older age (not specifically treated as an intervention, but analyzed as a variable)
Number of subjects: 491

Group type: EXPERIMENTAL
Intervention: History of acute mountain sickness
Number of subjects: 491

Group type: EXPERIMENTAL
Intervention: 40-year-old dichotomy
Number of subjects: 491

Group type: EXPERIMENTAL
Intervention: Decade of life
Number of subjects: 491
Study: 32501812

Group type: EXPERIMENTAL
Intervention: Prenatal treatment (specifics not provided)
Number of subjects: 0
Study: 34332537

Group type: EXPERIMENTAL
Intervention: Tai Chi Exercise (TCE)
Number of subjects: 68
Study: 33075592

Group type: EXPERIMENTAL
Intervention: Head-up positioning in acute stroke unit care
Number of subjects: 11086

Group type: COMPARATOR
Intervention: Head-down positioning in acute stroke unit care
Number of subjects: 11086
Study: 36279880

Group type: EXPERIMENTAL
Intervention: Combined use of EBUS‐TBNA and transbronchial mediastinal cryobiopsy
Number of subjects: 271

Group type: COMPARATOR
Intervention: EBUS‐TBNA alone
Number of subjects: 271
Study: 33514342

Group type: EXPERIMENTAL
Intervention: GROW standards
Number of subjects: 225

Group type: EXPERIMENTAL
Intervention: INTERGROWTH standards
Number of subjects: 225

Group type: EXPERIMENTAL
Intervention: WHO standards
Number of subjects: 225
Study: 32264698

Group type: EXPERIMENTAL
Intervention: Prothrombin complex concentrates (PCCs) administered to patients with factor Xa inhibitor-related ICH
Number of subjects: 663
Study: 36141729

Group type: EXPERIMENTAL
Intervention: Fully digital workflow
Number of subjects: 10

Group type: COMPARATOR
Intervention: Conventional workflow
Number of subjects: 10
Study: 32340638

Group type: EXPERIMENTAL
Intervention: IbET (internet-based extinction therapy)
Number of subjects: 311

Group type: COMPARATOR
Intervention: CTRL (internet-based stress-management training program)
Number of subjects: 311

Group type: EXPERIMENTAL
Intervention: IbET
Number of subjects: 311

Group type: COMPARATOR
Intervention: CTRL
Number of subjects: 311
Study: 36120805

Group type: EXPERIMENTAL
Intervention: Cold Atmospheric Plasma (CAP) technology, treated biweekly for five sessions with a follow-up 30 days after final treatment
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: Cold Atmospheric Plasma (CAP) technology
Number of subjects: 18

Group type: COMPARATOR
Intervention: Control (untreated side)
Number of subjects: 18
Study: 34008703

Group type: EXPERIMENTAL
Intervention: Epidural anesthesia with low-dose morphine (15 mcg/kg)
Number of subjects: 66

Group type: COMPARATOR
Intervention: Epidural anesthesia with clonidine (1 mcg/kg)
Number of subjects: 66
Study: 33759836

Group type: COMPARATOR
Intervention: Total Thyroidectomy (TT)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Total Thyroidectomy + Prophylactic Central Neck Dissection (TT + pCND)
Number of subjects: 60
Study: 35285535

Group type: EXPERIMENTAL
Intervention: Nurse-led sexual rehabilitation programme
Number of subjects: 172

Group type: COMPARATOR
Intervention: Attention control group
Number of subjects: 172
Study: 33049188

Group type: EXPERIMENTAL
Intervention: 16 French catheter
Number of subjects: 52

Group type: COMPARATOR
Intervention: 20 French catheter
Number of subjects: 52
Study: 33739422

Group type: EXPERIMENTAL
Intervention: TAILORED (personalized weight loss information)
Number of subjects: 459

Group type: EXPERIMENTAL
Intervention: TARGETED (generic weight loss information)
Number of subjects: 459

Group type: COMPARATOR
Intervention: CONTROL (general healthy body content)
Number of subjects: 459
Study: 32493459

Group type: EXPERIMENTAL
Intervention: Intravenous injection of expanded umbilical cord blood cells at a dose of 5 million cells/kg (maximum dose - 500 million cells)
Number of subjects: 24

Group type: COMPARATOR
Intervention: Standard supportive care
Number of subjects: 24
Study: 35278689

Group type: COMPARATOR
Intervention: Occipital tACS stimulation at 10 Hz
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Occipital tACS stimulation at 6 Hz
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Occipital tACS stimulation at 20 Hz
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Occipital tACS stimulation at 40 Hz
Number of subjects: 0

Group type: COMPARATOR
Intervention: Sham stimulation
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: 10 Hz tACS delivered to sensorimotor areas
Number of subjects: 0
Study: 33431075

Group type: EXPERIMENTAL
Intervention: Endovascular Therapy (EVT)
Number of subjects: 0
Study: 35852479

Group type: EXPERIMENTAL
Intervention: Dual-temperature zone mattress with cooler centre and warmer periphery plus STS pillow (30 min after lights-off)
Number of subjects: 11

Group type: COMPARATOR
Intervention: Control night (no intervention)
Number of subjects: 11
Study: 33781956

Group type: EXPERIMENTAL
Intervention: Real stimulation (1 Hz)
Number of subjects: 33

Group type: COMPARATOR
Intervention: Sham stimulation
Number of subjects: 33
Study: 34226144

Group type: EXPERIMENTAL
Intervention: Atezolizumab
Number of subjects: 1225
Study: 34860681

Group type: EXPERIMENTAL
Intervention: eHealth Resource Checklist
Number of subjects: 0
Study: 34427137

Group type: EXPERIMENTAL
Intervention: Radial Access (RA)
Number of subjects: 180

Group type: EXPERIMENTAL
Intervention: Femoral Access (FA)
Number of subjects: 180

Group type: EXPERIMENTAL
Intervention: Pedal Access (PA)
Number of subjects: 180
Study: 34837745

Group type: EXPERIMENTAL
Intervention: Nab-paclitaxel/gemcitabine (AG) followed by FOLFIRINOX (FFX)
Number of subjects: 91
Study: 34673925

Group type: EXPERIMENTAL
Intervention: Home adaptation service (Care&Repair Cymru)
Number of subjects: 657536

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 657536
Study: 32225936

Group type: EXPERIMENTAL
Intervention: Pattern randomization method with randomness (90%, 90%)
Number of subjects: 0

Group type: COMPARATOR
Intervention: One-dimensional periodic grid
Number of subjects: 0

Group type: COMPARATOR
Intervention: One-dimensional aperiodic grid
Number of subjects: 0

Group type: COMPARATOR
Intervention: Concentric rings structure
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Metal grid with randomness (90%, 90%)
Number of subjects: 0
Study: 34872440

Group type: EXPERIMENTAL
Intervention: Degarelix
Number of subjects: 52

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 52
Study: 32057658

Group type: EXPERIMENTAL
Intervention: Arthroscopic irrigation and debridement (I&D)
Number of subjects: 204

Group type: COMPARATOR
Intervention: Open irrigation and debridement (I&D)
Number of subjects: 204
Study: 32542906

Group type: EXPERIMENTAL
Intervention: Short-course exercise training (4–8 weeks supervised by a physiotherapist, phone contact every 2 weeks)
Number of subjects: 136

Group type: COMPARATOR
Intervention: Usual care (no physiotherapist or case manager input)
Number of subjects: 136

Group type: EXPERIMENTAL
Intervention: Short-course exercise training
Number of subjects: 136

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 136
Study: 32949705

Group type: EXPERIMENTAL
Intervention: Mepolizumab
Number of subjects: 35
Study: 34991541

Group type: EXPERIMENTAL
Intervention: Food-based recommendations (FBR)
Number of subjects: 123

Group type: COMPARATOR
Intervention: Non-Food-based recommendations (non-FBR)
Number of subjects: 123